For the year ending 2025-12-31, SIBN had $7,292K increase in cash & cash equivalents over the period. -$9,089K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -18,904 |
| Stock-based compensation | 25,524 |
| Depreciation and amortization | 5,770 |
| Accounts receivable credit losses | 570 |
| Inventory reserve | 1,997 |
| Amortization of discount and premium on marketable securities | 3,051 |
| Amortization of debt issuance costs | 117 |
| Loss on disposal of property and equipment | -1,627 |
| Accounts receivable | 3,027 |
| Inventory | 8,684 |
| Prepaid expenses and other assets | 1,030 |
| Accounts payable | -1,763 |
| Accrued liabilities and other | 179 |
| Net cash used in operating activities | -675 |
| Maturities of marketable securities | 205,100 |
| Purchases of marketable securities | 192,526 |
| Purchases of property and equipment | 8,414 |
| Net cash provided by (used in) investing activities | 4,160 |
| Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs | 0 |
| Proceeds from debt financing, net of debt issuance cost | 0 |
| Repayments of debt financing | 0 |
| Final payment fee related to debt | 0 |
| Proceeds from the exercise of common stock options | 1,169 |
| Proceeds from issuance of common stock under employee stock purchase plan | 2,207 |
| Net cash provided by financing activities | 3,376 |
| Effect of exchange rate changes on cash and cash equivalents | 431 |
| Net increase in cash and cash equivalents | 7,292 |
| Beginning of year | 34,948 |
| End of year | 42,240 |
SI-BONE, Inc. (SIBN)
SI-BONE, Inc. (SIBN)